The effect of the immunomodulator AS101 on Parkinson's disease

被引：0
作者：
Gefen, R [1 ]
Yadid, G [1 ]
Shalit, F [1 ]
Sredni, B [1 ]
机构：
[1] Bar Ilan Univ, CAIR Inst, Marilyn Finkler Canc Res Ctr, Dept Life Sci, Ramat Gan, Israel
来源：
EUROPEAN CYTOKINE NETWORK | 1998年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
351
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [21] PRE-TRANSPLANT DESENSITIZATION USING THE IMMUNOMODULATOR AS101: PRELIMINARY IN-VITRO RESULTS
    Israeli, Moshe
    Sredni, Benjamin
    Mor, Eitan
    Zakai, Chana
    Klein, Tirza
    HUMAN IMMUNOLOGY, 2009, 70 : S158 - S158
  • [22] INCREASED DNA-REPAIR ABILITY AFTER IRRADIATION FOLLOWING TREATMENT WITH THE IMMUNOMODULATOR AS101
    KALECHMAN, Y
    SHANI, A
    ALBECK, M
    BARKAI, IS
    SREDNI, B
    RADIATION RESEARCH, 1993, 136 (02) : 197 - 204
  • [23] The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats
    Halpert, G.
    Halperin Sheinfeld, M.
    Monteran, L.
    Sharif, K.
    Volkov, A.
    Nadler, R.
    Schlesinger, A.
    Barshak, I.
    Kalechman, Y.
    Blank, M.
    Shoenfeld, Y.
    Amital, H.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 203 (03) : 375 - 384
  • [24] Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake
    Frei, Gabi M.
    Lebenthal, Ilana
    Albeck, Michael
    Albeck, Amnon
    Sredni, Benjamin
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (05) : 712 - 722
  • [25] CYTOKINE SECRETION EFFECTED BY SYNERGISM OF THE IMMUNOMODULATOR AS101 AND THE PROTEIN-KINASE-C INDUCER BRYOSTATIN
    SREDNI, B
    KALECHMAN, Y
    ALBECK, M
    GROSS, O
    AURBACH, D
    SHARON, P
    SEHGAL, SN
    GURWITH, MJ
    MICHLIN, H
    IMMUNOLOGY, 1990, 70 (04) : 473 - 477
  • [26] A novel treatment for Parkinson's disease using an immunomodulator
    Sredni, B
    Yadid, G
    Albeck, M
    Shalit, F
    Gefen, R
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 40 - 40
  • [27] A novel treatment for Parkinson's disease using an immunomodulator
    Sredni, B
    Yadid, G
    Albeck, M
    Shalit, F
    Gefen, R
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 90 - 90
  • [28] The immunomodulator AS101 induces growth arrest and apoptosis in Multiple Myeloma: Association with the Akt/Survivin pathway
    Hayun, Michal
    Naor, Yaniv
    Weil, Merav
    Albeck, Michael
    Peled, Alpha
    Don, Jeremy
    Haran-Ghera, Nechama
    Sredni, Benjamin
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1423 - 1431
  • [29] INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AND IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES
    SREDNI, B
    ALBECK, M
    KALECHMAN, Y
    HEPATOLOGY, 1994, 19 (04) : I126 - I126
  • [30] INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AN IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES
    KALECHMAN, Y
    SHANI, A
    ALBECK, M
    SREDNI, B
    IMMUNOPHARMACOLOGY, 1995, 29 (02): : 149 - 158
12345